Clinical trial
Effects on Cytokines, Immunoglobulins, Antibodies, Sphingomyelinase and PAF Hydrolysis Capacity in the Maternal Milk After Probiotic VSL#3 Administration in the Last Four Weeks of Gestation and First Month of Lactation
NCT01367470 is registered in ClinicalTrials.gov with Policlinico Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects on Cytokines, Immunoglobulins, Antibodies, Sphingomyelinase and PAF Hydrolysis Capacity in the Maternal Milk After Probiotic VSL#3 Administration in the Last Four Weeks of Gestation and First Month of Lactation
- Lead sponsor
- Policlinico Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- December 31, 2013
- Enrollment
- 67 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
allergy